Cytoreductive surgery improves survival in colorectal peritoneal metastases.

In patients with colorectal peritoneal metastases, cytoreductive surgery has shown significant survival benefits, regardless of the use of intraperitoneal chemotherapy. Despite recent challenges to the efficacy of intraperitoneal treatments, the comprehensive review indicates that surgical intervention remains a crucial component in managing this aggressive form of cancer. The study emphasizes a critical analysis of current treatment protocols and the need for enhanced strategies to improve patient outcomes in colorectal cancer with peritoneal spread.